Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl M Hager

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Annals of Hematology|October 23, 2024
Overall survival in TP53-mutated AML and MDSChristian J Puzo, Karl M Hager, Henry M Rinder, et al.
Ejhaem|December 18, 2024
Optimization criteria for ordering myeloid neoplasm next-generation sequencingSavanah D Gisriel, John G Howe, Christopher A Tormey, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Annals of Hematology|October 23, 2024
Overall survival in TP53-mutated AML and MDSChristian J Puzo, Karl M Hager, Henry M Rinder, et al.
Ejhaem|December 18, 2024
Optimization criteria for ordering myeloid neoplasm next-generation sequencingSavanah D Gisriel, John G Howe, Christopher A Tormey, et al.
Pageof 1